rs2229749
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 1P and 20B. PP2BP4_StrongBP6_Very_StrongBA1
The NM_003922.4(HERC1):āc.11166G>Cā(p.Glu3722Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.826 in 1,611,522 control chromosomes in the GnomAD database, including 569,108 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.
Frequency
Consequence
NM_003922.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -19 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HERC1 | NM_003922.4 | c.11166G>C | p.Glu3722Asp | missense_variant | 57/78 | ENST00000443617.7 | NP_003913.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HERC1 | ENST00000443617.7 | c.11166G>C | p.Glu3722Asp | missense_variant | 57/78 | 1 | NM_003922.4 | ENSP00000390158 | P1 |
Frequencies
GnomAD3 genomes AF: 0.814 AC: 123679AN: 151980Hom.: 52185 Cov.: 31
GnomAD3 exomes AF: 0.739 AC: 184014AN: 249060Hom.: 74402 AF XY: 0.745 AC XY: 100673AN XY: 135112
GnomAD4 exome AF: 0.828 AC: 1208137AN: 1459424Hom.: 516876 Cov.: 33 AF XY: 0.824 AC XY: 598206AN XY: 726170
GnomAD4 genome AF: 0.814 AC: 123782AN: 152098Hom.: 52232 Cov.: 31 AF XY: 0.802 AC XY: 59596AN XY: 74354
ClinVar
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jul 05, 2018 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Macrocephaly, dysmorphic facies, and psychomotor retardation Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Aug 10, 2021 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at